Gilead’s HIV-1 medicine Biktarvy gets approval in Japan
Gilead Sciences Inc.'s once-daily HIV-1...
Read MoreGilead Sciences Inc.'s once-daily HIV-1...
Read MoreCambrex Corporation has announced the...
Read MoreBritish drugmaker AstraZeneca Plc said...
Read MoreElekta (STO:EKTA B) said today that...
Read MoreThe National Organization for Rare...
Read MoreHitGen Ltd announced that the...
Read MoreResearchers at the University of...
Read MoreEisai on Friday said it...
Read MoreResearchers have successfully frozen testicular...
Read MoreThe GenePOC Strep A assay...
Read More